• Home
  • Study Details

SARS-CoV-2 Vaccination in Immune-mediated Disease (no Vaccine provided)

To better understand how effective the COVID vaccine is in patients with autoimmune disease. **This study does not provide the COVID Vaccine*

Age & Gender

  • 2 years ~ 99 years
  • Male, Female, Gender Inclusive

Visit Availability

  • Standard business hours (M-F, 8-5)
  • Visits can be combined with regular clinical appointments


United States (Nationwide)

What will be asked of you

At each visit we will obtain a sample of blood. Whenever possible, we will time these visits to coincide with your normal medical visits.

In-person visits:
Phone or online visits:
Total length of participation:
4 study visits over 15 months

Looking for Specific Volunteers

Able to participate:

  • Vasculitis, glomerular diseases, or other autoimmune diseases
  • Plan to receive vaccination 1-3 months following enrollment or have completed SARS-CoV-2 vaccination course within the prior 1-3 months.
  • *Please note: This study does not provide any vaccine*

Not eligible if:

  • History of splenectomy
  • History of cancer with exposure to chemotherapy in the last two years
  • Active COVID-19 infection
  • History of uncontrolled HBV and HCV, and HIV
  • Received blood, blood products, or IVIG in the last three months.

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Visit Study Website

Primary Visit Location

Eastowne Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Manish Saha

Study Type

Clinical or Medical

Study Topics

Chronic Conditions
Healthy Volunteer or General Population
Immune System/Infections
Kidneys and Liver
Rare Diseases

IRB Number


logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.


  • This email address is being protected from spambots. You need JavaScript enabled to view it.